Lily Sarafan
Angel Investor
San Francisco, United States
Lily Sarafan is a seed investor in San Francisco focused on Health Care and Wellness. Lily Sarafan is the Executive Chair of TheKey. She is also an Operating Partner at Cota Capital.An active Stanford alum, Lily serves on the Stanford Alumni Association Board of Directors, the Freeman Spogli Institute Council, and the Stanford Undergraduate Education Cabinet. She is also Founding Partner of Project BIG: The Stanford Brain ImmuneGut Initiative. Lily's board service extends to other high-impact nonprofits including the Women's Alzheimer's Movement and the BerkeleyHaas Center for Innovation Economies, where she is board chair. An appointee to the California Governor’s Alzheimer's Task Force, Lily serves in various leadership roles to advance economic development, civic engagement, and precision health.Lily holds an M.S. in Management Science and Engineering and B.S. in Science, Technology, and Society from Stanford University, where she was Eben Tisdale Fellow and Class President. She has been named Ernst & Young Entrepreneur of the Year, Women Health Care Executives Woman of the Year, and a Silicon Valley 40 Under 40. Lily is a Member of Young Presidents' Organization, a Term Member of the Council on Foreign Relations, a Henry Crown Fellow of the Aspen Institute, and a World Economic Forum Young Global Leader.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lily Sarafan invests in
Stages Lily Sarafan invests in
Countries Lily Sarafan invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.3M–$25M
Investment Focus
Industry
- Health Care 3 (43%)
- Wellness 2 (29%)
- Enterprise Software 2 (29%)
- Artificial Intelligence 2 (29%)
- SaaS 1 (14%)
Stage
- Seed 4 (57%)
- Series A 1 (14%)
- Funding Round 1 (14%)
- Venture - Series Unknown 1 (14%)
Country
- United States 4 (57%)
- Israel 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care. | $25M / Series A / May 24, 2022 | ||
| Founded by veteran business executive Noosheen Hashemi and Stanford Professor of Genetics and personalized medicine pioneer Dr. Michael Snyder, January AI is a precision health platform that combines AI, multiomic data, and real-time behavioral signals to deliver deeply personalized metabolic insights and predictions for individuals and clinicians.January AI helps people understand how their body uniquely responds to food, activity, sleep, and other lifestyle factors. Through its mobile app, users can seamlessly track nutrition, integrate data from wearables, EHRs and continuous glucose monitors, and receive AI-driven insights that translate complex health data into simple, actionable recommendations. January also developed the world’s first virtual glucose monitor, enabling users to predict their blood sugar response to foods, with or without a physical CGM, making personalized metabolic health accessible at scale.Beyond the consumer experience, January AI powers a clinical intelligence platform. By integrating data across labs, wearables, genomics, and lifestyle inputs, January creates a dynamic health profile that surfaces patterns, identifies potential drivers of metabolic dysfunction, and supports personalized care plans. Clinicians and partners can leverage this intelligence to accelerate analysis, improve patient engagement, and deliver more precise, data-driven interventions. | $8.8M / Venture - Series Unknown / Feb 25, 2021 | ||
| Seniorly helps families and older adults find the right senior living for their needs and budget. Combining the power of machine learning with the high-touch support of a national network of local advisors, Seniorly is modernizing senior living discovery. Through its online platform, Seniorly provides access to thousands of senior livingcommunities, expert insights, and personalized recommendations based search preferences. Seniorly also has a growing marketplace of trusted companies, offering other services and products that are helpful to families at this stage of life. Founded in 2014, Seniorly currently supports over 5 million visitors every year on their senior living journey. Visit http://www.seniorly.com for more information. | $2.4M / Seed / Nov 24, 2017 | ||
| Mezmo, formerly LogDNA, is an observability platform to manage and take action on your data. It ingests, processes, and routes log data to fuel enterprise-level application development and delivery, security, and compliance use cases. | $1.3M / Seed / Jul 20, 2016 | ||
| Blueboard is the experiential rewards and recognition platform for the modern workplace. Its rewards platform allows companies to reward their employees to curated experiences and activities with the click of a button – things like skydiving, wine tasting, massage, and mixology. Its clients love the fact that it has made memorable and meaningfulrecognition as easy as sending a gift card.It was founded in 2013 and is based in San Francisco, California. | $2M / Seed / Jul 28, 2015 | ||
| See all 7 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lily Sarafan invest in?
Lily Sarafan invests primarily in Health Care, Wellness and Enterprise Software startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Lily Sarafan invest in?
Lily Sarafan typically joins rounds of $1.3M–$25M at Seed. These are whole funding-round sizes, not Lily Sarafan's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Lily Sarafan took part in.
How do I contact Lily Sarafan?
Public channels for Lily Sarafan include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Lily Sarafan last invest?
The most recent investment recorded for Lily Sarafan closed in May 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
